Uploaded by Jarka Nicholas

Dr.-Shabbits-Sept-11-lecture colour

advertisement

PCTH 325

Pharmacokinetics 2 and

Drug Dosing

Dr. Shabbits jennifer.shabbits@ubc.ca

September 11, 2014

Learning objectives

1. Describe the mechanisms of drug metabolism, the significance of enzyme induction & inhibition, and how the first-pass effect can influence dosing

2. Describe how drugs are excreted from the body and how pH can be manipulated to influence this process

3. Define and describe MTC, MEC and the therapeutic range

4. Describe, interpret and apply the C vs t equation and graph

5. Define and calculate t

½ fraction eliminated

, C max

, t max

, fraction remaining and

6. Describe the significance of steady state and how it can be achieved

7. Calculate loading and maintenance doses and describe how and when they are used

Metabolism

 the irreversible biotransformation of drug

• makes it more polar to ↑ renal (urinary) excretion

Occurs primarily in the liver via 2 (usually sequential) enzyme-catalyzed processes:

• Phase I oxidation/reduction/hydrolysis

• Phase II conjugation

Phase I: cytochrome P450 enzymes

A superfamily of related enzymes that add on or uncover small polar groups (–OH, –NH

2

, –COOH) water solubility to 

Phase 1

Metabolite Parent Drug

P450 Enzymes

P450 enzyme induction and inhibition

• some P450 enzymes can be induced or inhibited by other drugs, foods, pregnancy or disease

Induction:  metabolic activity of enzymes

 [Drug] (ex: alcohol)

Inhibition:  metabolic activity of enzymes

 [Drug] (ex: grapefruit juice)

 Primary cause of drug interactions

 Requires drug dosing to be increased or decreased

Phase II: conjugative enzymes

Mediated by various non-P450 liver enzymes

• covalently add large, polar, endogenous molecules to

Phase I metabolite

• ensures that metabolite is ready for excretion phenytoin

(glucuronide, glutathione, sulfate, acetate, amino acids etc)

Phase II glucuronyl transferase

Phase I

P450 p-OH-phenytoin phenytoin-ether-glucuronide

Drug metabolism

• usually inactivates the drug

• is required to activate prodrugs

Metabolite + Receptor

≠ MR complex

CYP2D6

Drug metabolism

• may be harmful if the metabolite(s) are toxic

Tylenol ® =

Acetaminophen

CYP2E1

Induced by alcohol

Toxic semiquinone

First pass metabolism

Most drugs absorbed from the GI tract are delivered to the liver before reaching the systemic circulation

IV Drug delivered to target receptors

 oral doses > iv doses to account for loss due to metabolism

Some drug is metabolised

(lost)

Oral

Drug

Drug metabolism in the gut

Some drugs undergo significant metabolism by bacterial enzymes in the gut (ex: digoxin)

What effect might a course of antibiotic therapy have in a person taking digoxin?

Excretion – kidney (renal excretion)

 The irreversible loss of drug from the body

Blood Proximal tubule

1. Passive Glomerular Filtration diffusion of small drugs <20kDa

Afferent arteriole

2. Active Tubular Secretion transport systems for large drugs Drug in blood

3. Passive Tubular Reabsorption concentration gradient may drive uncharged drug back into blood

*urine pH is key

Efferent arteriole

Urine

Weak acid:

Absorbed or Excreted?

HA

H + + A -

Weak base: B + H +

BH +

Changing urine pH to treat an overdose

 increasing urine pH shifts equilibrium to promote excretion of weak acid drugs

(ex: aspirin)

• iv sodium bicarbonate raises pH from 6-8

HA  H + +

A Ionized form is water soluble  excreted in urine

*Remember:  pH =  [H + ]

Changing urine pH to treat an overdose

How would you modify the urine pH to treat an overdose of a weak base drug?

B + H +  BH +

Changing urine pH to treat an overdose

 urine pH shifts equilibrium to promote excretion of weak base drugs

(ex: amphetamine)

Summary

Administration of agonist or antagonist

Enteral, parenteral, inhaled, topical, etc.

Steady state

Phase I, Phase II, prodrugs

Ionized drug - pH

Unionized drug - pH

Drug binds receptor(s)

Response desired? side effect?

TD

50

, ED

50

,

Part 4: Drug Dosing

Designing drug dosing regimens

How much drug?

• Magnitude of therapeutic (and toxic) effects depends on drug dose

How often?

• Magnitude of effect declines over time as drug levels decrease

For how long?

• Continuous drug use has a cost (economic, side effects, toxicity)

0

Concentration – time relationships

• follow and predict drug concentration in the body

• blood is the reference → delivers drug to receptors

? iv

? non-iv

Administer drug

Take blood samples at various times

Measure [drug]

Plot data

Time

Concentration – time relationships

• allow us to ‘visualize’ the ADME processes

0

Time

Concentration – time relationships

• show us the magnitude & duration of the effect

C max

MTC (minimum toxic conc.)

Therapeutic Range

MEC (minimum effective conc.)

0 t max Time

The C vs t equation – iv administration

C t

= C

0 e -kt

C

0

 e = base of the natural logarithm

C t

= drug conc at time ‘t’

C

0

= drug conc at time ‘0’ k = first order elimination rate constant

→ the fraction of drug eliminated per unit time

C t

0

0 t

Time

Linearizing the C vs t equation

Exponential: C t

= C

0 e -kt

Log e

(or ln): lnC t

= -kt + lnC

0

Y = mX + b lnC

0 use these equations to predict drug concentration at various times

Slope = -k

Time (t)

Application of k: half-life ( t

½

)

Elimination half-life (t

½

): the time required for drug concentration to decrease by half t

½

= ln2 = 0.693

k k

Sample Calculation:

The first order elimination rate constant for acetaminophen (Tylenol®) is 0.23 hr -1 .

What is its half-life?

Note units k: time -1 t

½

: time

Application of t

½

:

drug washout

# Elimination half-lives

0

1

2

3

4

5

% Drug

Remaining

100

50

25

12.5

6.25

3.13

% Drug

Eliminated

0

50

75

87.5

93.75

96.87

Used to estimate “drug washout” prior to surgery, following a drug overdose etc.  ~5 half-lives for drug to be ‘completely’ eliminated

Question…

A person presents to the ER following an overdose of Tylenol ( t

½

= 3 hrs). How long will it take for the drug to get out of his system without any medical intervention?

Application of C vs t eqn: predicting [drug]

If the initial plasma concentration of Tylenol is 20 μ g/ml, what will the plasma concentration be after 8 hours?

Use C t

= C

0 e -kt or lnC t

= -k t + lnC

0

Step 1: lnC

8h

= -kt + lnC

0

Step 2:

Step 3:

Step 4:

Drugs can be taken in single doses

Single drug dosing often puts drug concentration in the therapeutic range for too short a time, if at all

Not even reached

Too brief

Time Time

Drugs can be taken in multiple doses

Peak (max) & trough (min) concentrations fluctuate around a prolonged steady state mean (C ss

)

Peaks

Troughs

Steady state concentration

Steady state occurs when the rate of drug administration = the rate of drug elimination, which takes ~ 5 half-lives

Time

Css

Drug input

Drug output

Administration = Elimination

(rate in = rate out)

Steady state concentration

Steady state can occur at ANY concentration. The goal is to have C ss fall within the therapeutic range

The concentration is a function of:

• drug dose

• dosing interval

Css

Time

Getting to steady state

A proper dosing regimen will put C ss in the therapeutic range. There are 2 approaches:

5

6

3

4

0

1

2

1. Exponential approach: give small, repeat doses at intervals ≈ the drug’s half-life (ex: 200 mg every 4 hr)

# t

½

12

16

20

24

4

8

Time (hr) Amount previous dose left (mg)

0 0

100

150

175

187.5

193.75

196.88

200

200

200

200

New Dose

(mg)

200

200

200

Total amount in body (mg)

200

300

350

375

387.5

393.8

396.9

2. Give a loading dose followed by maintenance doses

Loading dose (LD)

• A large dose of drug used to raise the plasma concentration to a therapeutic (target) level faster than with smaller repeat doses

LD = C target x V d where C target

= desired C ss

Intermittent, non-iv administration

Maintenance dose (MD)

• Smaller repeat doses are then used to maintain the desired plasma concentration

• The MD replaces the drug that is eliminated by the body during the dosing interval ‘t’ (ie the time between doses)

MD = (fraction eliminated) x LD = (1-e -kt ) x LD

Rearranging C t

= C

0 e -kt gives us the:

Fraction remaining (C t

/C

0

) = e -kt

 Fraction eliminated = 1-e -kt

Practice

problem

The target concentration of a drug to be given 3 times a day is 35 mg/L. The Vd = 25 L and t

1/2

= 12 h.

What loading and maintenance doses would be appropriate?

Practice

problem – cont’d

MD = (1-e -kt ) x LD

What is k?

What is t?

 the technical dosing regimen would be:

 the practical dosing regimen would be:

Therapeutic drug monitoring

• Provides individualized (patient-specific) dosing information

Give an initial dose based on expected, published averages

Measure the patient’s actual plasma concentration

Revise subsequent dosing

• Useful for drugs with narrow therapeutic range & special populations

(ex: geriatrics, pregnancy, pediatrics)

Derivation of the half-life equation ~ FYI

lnC t

= lnC

0

-kt ln(C t

/C

0

) = -kt multiply through by -1 ln(C

0

/C t

) = kt when t = t

½

C t

= ½C

0 or C

0

= 2C t ln(2C t

/C t

) = kt

½ ln2 = kt

½ t

½

= ln2/k = 0.693/k

Download